-
Announcement of NMPA and General Administration of Customs on the Establishment of Aidian Port as a Crude Drug Import Port
2022-03-16
According to the Drug Administration Law of the People's Republic of China, upon the approval of the State Council, it is agreed to establish Aidian Port, Chongzuo City, Guangxi Zhuang Autonomous Region (hereinafter referred to as Aidian Port) as a crude drug import port.
-
NMPA Announcement on Issuing the Provisions for the Administration of Adverse Reaction Monitoring of Cosmetics
2022-02-15
The NMPA formulated the Provisions for the Administration of Adverse Reaction Monitoring of Cosmetics, which was issued on February 15, 2022 and will come into force on October 1, 2022.
-
NMPA Announcement on the Good Manufacturing Practice for Cosmetics
2022-01-07
NMPA organized to formulate the Good Manufacturing Practice for Cosmetics (hereinafter referred to as the GMP), which was issued on January 6, and shall enter into force as of July 1, 2022.
-
NMPA Announcement on the Emergency Approval Procedure for Medical Devices
2021-12-29
National Medical Products Administration organized to revise the Emergency Approval Procedure for Medical Devices, which is issued and take effect as of December 29, 2021.
-
NMPA Announcement on Issuing the Provisions for Administration of Self-Test for Medical Device Registration
2021-10-22
The NMPA organized to formulate the Provisions for Self-Test for Medical Device Registration, The Provisions for Self-Test for Medical Device Registration was issued and implemented on October 22, 2021.
-
NMPA Announcement on Revising the Package Insert of Antiviral Syrup, Capsules, Soft Capsules, Pills (Concentrated Pills), Dropping Pills, Tablets, Effervescent Tablets, Chewable Tablet, Oral Liquid, And Granules
2021-10-12
The NMPA decided to revise such items as [Adverse reactions], [Contraindications] and [Precautions] in the package inserts of antiviral syrup, capsules, soft capsules, pills (concentrated pills), dropping pills, tablets, effervescent tablets, chewable tablet, oral liquid, and granules.